Statement Of Changes In Equity [Abstract]

Biocartis Group NV - Filing #3123157

Concept	As at 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Equity	526,405,000 EUR	5,572,000 EUR	—	—	33,897,000 EUR	—	33,897,000 EUR	711,874,000 EUR	6,862,000 EUR	220,657,000 EUR	—	—	455,343,000 EUR	—	36,824,000 EUR	220,657,000 EUR	—	—	711,874,000 EUR	6,102,000 EUR	5,153,000 EUR	—	36,824,000 EUR	—	84,480,000 EUR	5,291,000 EUR	698,027,000 EUR	84,480,000 EUR	392,259,000 EUR	4,670,000 EUR	220,668,000 EUR
Changes in equity [abstract]
Comprehensive income [abstract]
Profit (loss)	—	—	—	71,472,000 EUR	—	—	—	—	—	—	71,472,000 EUR	71,472,000 EUR	—	62,934,000 EUR	—	—	62,934,000 EUR	—	—	—	—	—	—	62,934,000 EUR	—	—	—	—	—	—	—
Comprehensive income	—	—	419,000 EUR	71,481,000 EUR	—	—	—	—	—	—	71,481,000 EUR	71,062,000 EUR	—	62,945,000 EUR	—	—	63,084,000 EUR	—	—	—	—	139,000 EUR	—	62,945,000 EUR	—	—	—	—	—	—	—
Increase (decrease) through share-based payment transactions, equity	—	—	—	760,000 EUR	—	760,000 EUR	—	—	—	—	760,000 EUR	—	—	1,432,000 EUR	—	—	—	1,432,000 EUR	—	—	—	—	—	1,432,000 EUR	—	—	—	—	—	—	—